Askar Nisar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Askar Nisar has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abbas Khan
Hayatabad Medical Complex, Peshawar, Pakistan
1 shared publication - Alina Batool
Khyber Girls Medical College, Peshawar, Pakistan
1 shared publication - Jaweria Farman
Khyber Girls Medical College, Peshawar, Pakistan
1 shared publication - Muhammad Hassaan Javaid
Department of Medicine Shifa College of Medicine Islamabad Pakistan
1 shared publication - Okasha Tahir
Hayatabad Medical Complex, Peshawar, Pakistan
1 shared publication - Raghabendra Kumar Mahato
Gandaki Medical College Teaching Hospital and Research Center, Pokhara, Nepal
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Nephrology
- Vol. 2026 (1) , 7218869
Liddle Syndrome Presenting as Hypertensive Crisis and Myocardial Injury in a Young Male: A Case Report
Introduction: Liddle’s syndrome is a rare inherited disorder associated with early‐onset and resistant hypertension due to hyperactivity of epithelial sodium channels (ENaCs). The condition is caused by mutations in the genes SCNN1A, SCNN1B, and SCNN1G. Liddle’s syndrome leads to hypertension, hypokalemia, and metabolic alkalosis. Case Presentation: A previously healthy 21‐year‐old male patient complained of severe central chest pain radiating to both arms and had a hypertensive emergency with a BP reading of 267/170 mmHg. The patient had marked elevation in troponin I (13.9 ng/mL), hypokalemia (2.8 mmol/L), and metabolic alkalosis. The electrocardiogram showed left ventricular hypertrophy with a strain pattern and QTc prolongation due to hypokalemia. Coronary angiography ruled out the possibility of primary acute coronary syndrome by revealing normal coronary arteries. Echocardiogram showed concentric left ventricular hypertrophy with normal ejection fraction and no wall motion abnormalities. In search of the secondary cause of hypertension, renal Doppler ultrasonography and aldosterone‐to‐renin ratio were normal, thus ruling out primary hyperaldosteronism. About the typical clinical and biochemical presentation, a clinical diagnosis of Liddle syndrome was highly likely. Genetic tests were not performed owing to financial constraints. However, treatment with amiloride brought about remarkable improvement in the control of hypertension and normalization of potassium levels. Conclusion: Liddle’s syndrome should be suspected in cases where there are young individuals who have severe hypertension, hypokalaemia, and an aldosterone‐to‐renin ratio that is normal or low. The diagnosis must be made promptly because delay may lead to complications. In instances where molecular testing is impractical, treatment with ENaC inhibition using amiloride is diagnostic and potentially life‐saving.
- 1 January 2026
- Published by Wiley in Case Reports in Nephrology
- Vol. 2026 (1) , 7218869
Open AccessLiddle Syndrome Presenting as Hypertensive Crisis and Myocardial Injury in a Young Male: A Case Report
Introduction: Liddle’s syndrome is a rare inherited disorder associated with early‐onset and resistant hypertension due to hyperactivity of epithelial sodium channels (ENaCs). The condition is caused by mutations in the genes SCNN1A, SCNN1B, and SCNN1G. Liddle’s syndrome leads to hypertension, hypokalemia, and metabolic alkalosis. Case Presentation: A previously healthy 21‐year‐old male patient complained of severe central chest pain radiating to both arms and had a hypertensive emergency with a BP reading of 267/170 mmHg. The patient had marked elevation in troponin I (13.9 ng/mL), hypokalemia (2.8 mmol/L), and metabolic alkalosis. The electrocardiogram showed left ventricular hypertrophy with a strain pattern and QTc prolongation due to hypokalemia. Coronary angiography ruled out the possibility of primary acute coronary syndrome by revealing normal coronary arteries. Echocardiogram showed concentric left ventricular hypertrophy with normal ejection fraction and no wall motion abnormalities. In search of the secondary cause of hypertension, renal Doppler ultrasonography and aldosterone‐to‐renin ratio were normal, thus ruling out primary hyperaldosteronism. About the typical clinical and biochemical presentation, a clinical diagnosis of Liddle syndrome was highly likely. Genetic tests were not performed owing to financial constraints. However, treatment with amiloride brought about remarkable improvement in the control of hypertension and normalization of potassium levels. Conclusion: Liddle’s syndrome should be suspected in cases where there are young individuals who have severe hypertension, hypokalaemia, and an aldosterone‐to‐renin ratio that is normal or low. The diagnosis must be made promptly because delay may lead to complications. In instances where molecular testing is impractical, treatment with ENaC inhibition using amiloride is diagnostic and potentially life‐saving.